AMERICAN LABORATORIES, LLC – Trademark Portfolio
Entity Type: 16
AMERICAN LABORATORIES, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include PANC-ZYME, AMERI-FLEX, PHARMATONE, MICROBIOTONE, and PROTEOSE-MICRO. The owner is based in Omaha, NE.
11128 John Galt Blvd., Suite 500
Omaha, NE 68137
Showing of trademarks Trademarks
Trademark Classifications
AMERICAN LABORATORIES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does AMERICAN LABORATORIES, LLC have?
AMERICAN LABORATORIES, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.
What trademark classes does AMERICAN LABORATORIES, LLC file in?
AMERICAN LABORATORIES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are AMERICAN LABORATORIES, LLC's most well-known trademarks?
AMERICAN LABORATORIES, LLC's registered trademark portfolio includes well-known marks such as PANC-ZYME, AMERI-FLEX, PHARMATONE, MICROBIOTONE, and PROTEOSE-MICRO. These are among 5 currently registered trademarks in the portfolio.
What is AMERICAN LABORATORIES, LLC's trademark registration success rate?
AMERICAN LABORATORIES, LLC has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.